Morie A. Gertz, MD

This month Morie A. Gertz, MD, discusses whether a mostly asymptomatic patient with amyloidosis should receive systemic therapy. And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!

There’s a basic formula for presentations of any kind: “Tell them what you are going to tell them; then tell them; and then tell them what you told them.” Of course, if you have ever sat through a 10-minute presentation with 50 slides covering every bit of data in the known world – or, if [...]